# Use of Epidurals Intraoperatively for Patients Undergoing Pancreas Resection

> **NCT03434678** · PHASE3 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 133 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** Propofol+ Rocuronium+ Fentanyl 2 mcg/kg+ Inhalational Agent, Bupivacaine 0.125% + Fentanyl 5 mcg/ml
- **DRUG:** Propofol+ Rocuronium+ Fentanyl + Inhalational
- **PROCEDURE:** Open Pancreaticoduodenectomy

## Key facts

- **NCT ID:** NCT03434678
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-30
- **Primary completion:** 2024-07-10
- **Final completion:** 2024-07-10
- **Target enrollment:** 133 (ACTUAL)
- **Last updated:** 2025-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03434678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03434678, "Use of Epidurals Intraoperatively for Patients Undergoing Pancreas Resection". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03434678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*